• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number EVD35-07-020-120
Medical Device Problem Codes Premature Activation (1484); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/19/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Physician was attempting to use an everflex entrust self-expanding stent along with a 6fr non-medtronic sheath and a 0.035 non-medtronic guidewire during treatment of 10mm plaque lesion in the patients right mid common iliac artery.Minimal vessel tortuosity and moderate vessel calcification are reported.Artery diameter reported as 7mm.Lesion exhibited 75% stenosis.There were no abnormalities reported in relation to anatomy.Embolic protection was not used.There was no damage noted to packaging (i.E.Shelf carton, hoop/tray).There were no issues noted when removing the device from the hoop/tray.The device was prepped per the ifu with no issues identified.The thumbscrew/lock-pin was checked for securement prior to procedure.The lesion was not pre or post dilated.The device did not pass through a previously-deployed stent.No resistance was encountered when advancing the device.Pre-deployment on the way to target site was reported.The stent remains in the patient and no attempts were made to remove stent.Deformation was noted to the deployed stent.One distal marker of the four looks to be bent back.The delivery system was safely removed from patient.No actions taken as a result of the pre-deployment.No vessel damage reported.Stent placed, just about at lesion, but lesion opened and procedure was completed.No patient injury reported.
 
Additional Manufacturer Narrative
Product analysis the device was returned with the red safety lock pin in place, the strain relief was confirmed as 20mm no stent was returned with the device and the stent pusher was observed in the device at approx.20mm.The red safety lock pin was removed, and the deployment wheel was moved in the direction of the arrow, it was advanced until the stent pusher was visible, biologics were also visible on the stent pusher medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD
Common Device Name
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key18931759
Report Number2183870-2024-00089
Device Sequence Number11907141
Product Code NIP
UDI-Device Identifier00821684051412
UDI-Public00821684051412
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P110023
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date05/22/2026
Device Catalogue NumberEVD35-07-020-120
Device Lot NumberB568520
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/19/2024
Supplement Date Received by Manufacturer04/25/2024
Initial Report FDA Received Date03/19/2024
Supplement Report FDA Received Date04/26/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/23/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age74 YR
Patient SexFemale
Patient Weight95 KG
-
-